Quercetin Promotes Degradation of Survivin and Thereby Enhances Death-receptor-mediated Apoptosis in Glioma Cells

Overview

Journal Neuro Oncol

Publisher Oxford University Press

Specialties Neurology
Oncology

Date 2008 Oct 31

PMID 18971417

Citations 48

Authors

Markus D Siegelin

David E Reuss

Antje Habel

Abdelhaq Rami

Andreas von Deimling

Affiliations

Soon will be listed here.

Abstract

The flavonoid quercetin has been reported to inhibit the proliferation of cancer cells, whereas it has no effect on nonneoplastic cells. U87-MG, U251, A172, LN229, and U373 malignant glioma cells were treated with quercetin (50-200 microM). Quercetin did not cause cytotoxicity 24 h after treatment. Combining quercetin with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) strongly augmented TRAIL-mediated apoptosis in U87-MG, U251, A172, and LN229 glioma cells; U373 cells could not be sensitized by quercetin to TRAIL-mediated apoptosis. TRAIL-induced apoptosis was enhanced by quercetin-induced reduction of survivin protein levels. Upon treatment with quercetin, the protein level of survivin was strongly suppressed in U87-MG, U251, and A172 but not in U373 glioma cells. Quercetin exposure resulted in proteasomal degradation of survivin. TRAIL-quercetin-induced apoptosis was markedly reduced by overexpression of survivin. In addition, upon treatment with quercetin, downregulation of survivin was also regulated by the Akt pathway. Taken together, the results of the present study suggest that quercetin sensitizes glioma cells to death-receptor-mediated apoptosis by suppression of inhibitor of the apoptosis protein survivin.

Citing Articles

Potential of Natural Products in the Treatment of Glioma: Focus on Molecular Mechanisms.

Sheida A, Farshadi M, Mirzaei A, Najjar Khalilabad S, Zarepour F, Taghavi S Cell Biochem Biophys. 2024; 82(4):3157-3208.

PMID: 39150676 DOI: 10.1007/s12013-024-01447-x.

Quercetin and microRNA Interplay in Apoptosis Regulation: A New Therapeutic Strategy for Cancer?.

Wang Z, Liu Y, Asemi Z Curr Med Chem. 2023; 32(5):939-957.

PMID: 38018191 DOI: 10.2174/0109298673259466231031050437.

Matteucinol combined with temozolomide inhibits glioblastoma proliferation, invasion, and progression: an in vitro, in silico, and in vivo study.

Netto J, Melo E, Oliveira A, Sousa L, Santiago L, Santos D Braz J Med Biol Res. 2022; 55:e12076.

PMID: 36000612 PMC: 9394692. DOI: 10.1590/1414-431X2022e12076.

A miR-137-XIAP axis contributes to the sensitivity of TRAIL-induced cell death in glioblastoma.

Geng F, Yang F, Liu F, Zhao J, Zhang R, Hu S Front Oncol. 2022; 12:870034.

PMID: 35965517 PMC: 9366219. DOI: 10.3389/fonc.2022.870034.

An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile.

De Angelis M, Francescangeli F, Nicolazzo C, Signore M, Giuliani A, Colace L J Exp Clin Cancer Res. 2022; 41(1):86.

PMID: 35260172 PMC: 8903172. DOI: 10.1186/s13046-022-02263-y.

References

Panner A, James C, Berger M, Pieper R . mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol Cell Biol. 2005; 25(20):8809-23. PMC: 1265779. DOI: 10.1128/MCB.25.20.8809-8823.2005. View

de Vries E, Gietema J, de Jong S . Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications. Clin Cancer Res. 2006; 12(8):2390-3. DOI: 10.1158/1078-0432.CCR-06-0352. View

Chen W, Wang X, Zhuang J, Zhang L, Lin Y . Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells. Carcinogenesis. 2007; 28(10):2114-21. DOI: 10.1093/carcin/bgm133. View

Granado-Serrano A, Martin M, Bravo L, Goya L, Ramos S . Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J Nutr. 2006; 136(11):2715-21. DOI: 10.1093/jn/136.11.2715. View

MIDDLETON Jr E, Kandaswami C, Theoharides T . The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000; 52(4):673-751. View

Surh Y, Ferguson L . Dietary and medicinal antimutagens and anticarcinogens: molecular mechanisms and chemopreventive potential--highlights of a symposium. Mutat Res. 2003; 523-524:1-8. DOI: 10.1016/s0027-5107(02)00343-3. View

Nesterov A, Lu X, Johnson M, Miller G, Ivashchenko Y, Kraft A . Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem. 2001; 276(14):10767-74. DOI: 10.1074/jbc.M005196200. View

Wagenknecht B, Glaser T, Naumann U, Kugler S, Isenmann S, Bahr M . Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ. 1999; 6(4):370-6. DOI: 10.1038/sj.cdd.4400503. View

Shen S, Chen Y, Hsu F, Lee W . Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade. J Cell Biochem. 2003; 89(5):1044-55. DOI: 10.1002/jcb.10559. View

10.

Liston P, Young S, Mackenzie A, Korneluk R . Life and death decisions: the role of the IAPs in modulating programmed cell death. Apoptosis. 1997; 2(5):423-41. DOI: 10.1023/a:1026465926478. View

11.

Kim Y, Lee Y . TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation. J Cell Biochem. 2006; 100(4):998-1009. DOI: 10.1002/jcb.21098. View

12.

Holcik M, Gibson H, Korneluk R . XIAP: apoptotic brake and promising therapeutic target. Apoptosis. 2001; 6(4):253-61. DOI: 10.1023/a:1011379307472. View

13.

Surh Y . Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003; 3(10):768-80. DOI: 10.1038/nrc1189. View

14.

Singhal R, Yeh Y, Praja N, Olah E, Sledge Jr G, Weber G . Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun. 1995; 208(1):425-31. DOI: 10.1006/bbrc.1995.1355. View

15.

Deng Y, Lin Y, Wu X . TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev. 2002; 16(1):33-45. PMC: 155309. DOI: 10.1101/gad.949602. View

16.

Deveraux Q, Reed J . IAP family proteins--suppressors of apoptosis. Genes Dev. 1999; 13(3):239-52. DOI: 10.1101/gad.13.3.239. View

17.

Yang C, Landau J, Huang M, Newmark H . Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr. 2001; 21:381-406. DOI: 10.1146/annurev.nutr.21.1.381. View

18.

Siegelin M, Touzani O, Toutain J, Liston P, Rami A . Induction and redistribution of XAF1, a new antagonist of XIAP in the rat brain after transient focal ischemia. Neurobiol Dis. 2005; 20(2):509-18. DOI: 10.1016/j.nbd.2005.04.006. View

19.

Ong C, Tran E, Nguyen T, Ong C, Lee S, Lee J . Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. Oncol Rep. 2004; 11(3):727-33. View

20.

Koschny R, Ganten T, Sykora J, Haas T, Sprick M, Kolb A . TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window. Hepatology. 2007; 45(3):649-58. DOI: 10.1002/hep.21555. View